Mike Scott

8.4k total citations · 3 hit papers
46 papers, 5.9k citations indexed

About

Mike Scott is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Mike Scott has authored 46 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Genetics and 17 papers in Hematology. Recurrent topics in Mike Scott's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Mike Scott is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Mike Scott collaborates with scholars based in United Kingdom, Australia and United States. Mike Scott's co-authors include Anthony R. Green, Linda M. Scott, Wendy N. Erber, Peter J. Campbell, Anthony J. Bench, George S. Vassiliou, Elaine Boyd, Clare East, E. Joanna Baxter and S Swanton and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mike Scott

46 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

2005 2.6k citations E. Joanna Baxter, Linda M. Scott et al. The Lancet profile →
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

2007 898 citations Linda M. Scott, Wei Tong et al. New England Journal of Medicine profile →
Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis

2015 357 citations Thomas McKerrell, Naomi Park et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Scott United Kingdom	24	4.4k	3.1k	3.1k	1.8k	776	46	5.9k
Alistair Reid United Kingdom	25	2.4k 0.6×	389 0.1×	2.8k 0.9×	1.4k 0.8×	386 0.5×	70	3.6k
Jan Cools Belgium	55	1.5k 0.3×	3.0k 1.0×	2.8k 0.9×	1.8k 1.0×	1.8k 2.3×	185	8.5k
J Gäbert France	19	1.0k 0.2×	1.3k 0.4×	2.6k 0.9×	404 0.2×	403 0.5×	38	3.9k
Lucienne Michaux Belgium	38	1.3k 0.3×	1.3k 0.4×	1.6k 0.5×	358 0.2×	1.1k 1.4×	184	4.5k
Anupriya Agarwal United States	28	1.2k 0.3×	1.4k 0.4×	1.7k 0.6×	418 0.2×	497 0.6×	85	3.1k
Montserrat Baiget Spain	42	1.4k 0.3×	3.8k 1.2×	554 0.2×	220 0.1×	856 1.1×	229	5.8k
Rafael Bejar United States	29	2.0k 0.5×	2.3k 0.8×	4.2k 1.4×	161 0.1×	504 0.6×	94	5.9k
Eric Sariban Belgium	36	1.4k 0.3×	1.1k 0.4×	1.0k 0.3×	136 0.1×	518 0.7×	107	3.5k
Barbara Hildebrandt Germany	29	1.4k 0.3×	1.5k 0.5×	3.1k 1.0×	101 0.1×	444 0.6×	115	4.1k
Michaela Liedtke United States	36	624 0.1×	2.5k 0.8×	1.7k 0.6×	319 0.2×	2.1k 2.8×	167	5.0k

Countries citing papers authored by Mike Scott

Since Specialization

Citations

This map shows the geographic impact of Mike Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Scott more than expected).

Fields of papers citing papers by Mike Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Scott. The network helps show where Mike Scott may publish in the future.

Co-authorship network of co-authors of Mike Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Scott. A scholar is included among the top collaborators of Mike Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Scott. Mike Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McKerrell, Thomas, Naomi Park, Thaidy Moreno-Rodriguez, et al.. (2015). Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis. Cell Reports. 10(8). 1239–1245. 357 indexed citations breakdown →

Scott, Mike, et al.. (2014). Abstract 2671: Targeting the KRAS signaling naocluster protein CNKSR1 provides antitumor activity against mutant KRAS xenografts. Cancer Research. 74(19_Supplement). 2671–2671. 1 indexed citations

Wright, Penny, et al.. (2013). Pitfalls in the Diagnosis of Anaplastic Large Cell Lymphoma with a Small Cell Pattern. SHILAP Revista de lepidopterología. 2013. 1–6. 1 indexed citations

Grigoropoulos, Nicholas F., Russell C. Petter, Mars B. van ’t Veer, Mike Scott, & George Follows. (2013). Leukaemia update. Part 1: diagnosis and management. BMJ. 346(mar28 4). f1660–f1660. 14 indexed citations

Boyd, Elaine, Anthony J. Bench, Mars B. van ’t Veer, et al.. (2011). High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies. British Journal of Haematology. 155(5). 609–612. 55 indexed citations

Dawson, Mark A., Jayne Curry, Philip Beer, et al.. (2010). AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders. British Journal of Haematology. 150(1). 46–57. 41 indexed citations

Sedić, Mirela, Peter Gehrig, Mike Scott, et al.. (2008). Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2- α ]quinoline in colon cancer cells depending on their p53 status. Molecular Cancer Therapeutics. 7(7). 2121–2132. 39 indexed citations

Polymenidou, Magdalini, Rita Moos, Mike Scott, et al.. (2008). The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes. PLoS ONE. 3(12). e3872–e3872. 146 indexed citations

Pavelić, Sandra Kraljević, Mirela Sedić, Karlo Hock, et al.. (2008). An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease. The Journal of Pathology. 217(4). 524–533. 25 indexed citations

10.

Scott, Linda M., Wei Tong, Ross L. Levine, et al.. (2007). JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis. New England Journal of Medicine. 356(5). 459–468. 898 indexed citations breakdown →

11.

Liu, Hongxiang, Anthony J. Bench, Chris M. Bacon, et al.. (2007). A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology. British Journal of Haematology. 138(1). 31–43. 94 indexed citations

12.

Scott, Mike, et al.. (2007). Application of growth factor stimulants improves cytogenetic analysis of chronic myeloproliferative disorder patients without alteration to cell lineage or clonality. Cancer Genetics and Cytogenetics. 175(2). 98–106. 1 indexed citations

13.

Follows, George, Pawan Dhami, Berthold Göttgens, et al.. (2006). Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites. Genome Research. 16(10). 1310–1319. 32 indexed citations

14.

Haworth, Charles, et al.. (2006). Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 174(3). 306–311. 44 indexed citations

15.

Pavelić, Sandra Kraljević, Mirela Sedić, Mike Scott, et al.. (2006). Casting light on molecular events underlying anti-cancer drug treatment: What can be seen from the proteomics point of view?. Cancer Treatment Reviews. 32(8). 619–629. 20 indexed citations

16.

Christopherson, Richard I., Nicole Barber, Larissa Belov, et al.. (2006). Classification of AML Using a Monoclonal Antibody Microarray. Humana Press eBooks. 125. 241–252. 10 indexed citations

17.

Campbell, Peter J., Linda M. Scott, Georgina Buck, et al.. (2005). Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. The Lancet. 366(9501). 1945–1953. 473 indexed citations

18.

Bord, S, et al.. (2004). Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. British Journal of Haematology. 126(2). 244–251. 49 indexed citations

19.

Joannides, Alexis, et al.. (2003). Postnatal Astrocytes Promote Neural Induction from Adult Human Bone Marrow–Derived Stem Cells. Journal of Hematotherapy & Stem Cell Research. 12(6). 681–688. 33 indexed citations

20.

Marley, S. B., John L. Lewis, Mike Scott, J M Goldman, & M. Y. Gordon. (1996). Evaluation of ‘discordant maturation’ in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU‐GM). British Journal of Haematology. 95(2). 299–305. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact